Immunotoxin Assay for Small Cell Lung Cancer
Author Information
Author(s): E.J. Derbyshire, L. de Leij, E.J. Wawrzynczak
Primary Institution: Institute of Cancer Research
Hypothesis
An immunotoxin made by linking ricin A chain to a cluster 2 Mab should be selectively and potently toxic to SCLC cell lines.
Conclusion
The study found that MOC-31-ricin A chain was potently and selectively toxic to human lung carcinoma cell lines expressing the cluster 2 antigen.
Supporting Evidence
- MOC-31-ricin A chain was toxic to NCI-H69 cells in a concentration-dependent manner.
- The indirect assay grossly overestimated the cytotoxic potency of MOC-31-ricin A chain.
- MOC-31-ricin A chain demonstrated no selective toxic effects against the NCI-H23 lung adenocarcinoma cell line.
Takeaway
Researchers created a special treatment that targets lung cancer cells and found it works really well against those cells.
Methodology
The study involved treating SCLC cell lines with monoclonal antibodies linked to ricin A chain and measuring cytotoxic effects using an indirect assay.
Limitations
The indirect assay overestimated the potency of the immunotoxin unless the concentrations of the screening agent and Mab were matched.
Want to read the original?
Access the complete publication on the publisher's website